Public Release: 

Children with fragile X syndrome have a bias toward threatening emotion

Reports new study in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging


Philadelphia, PA, August 23, 2017 - Anxiety occurs at high rates in children with fragile X syndrome (FXS), the most common form of inherited intellectual disability. Children with co-occurring anxiety tend to fare worse, but it can be hard to identify in infants. A new study in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging reports that infants and children with FXS show bias toward threatening emotion, rather than positive emotion, a pattern highly linked with anxiety. The study was led by Dr. Susan Rivera of University of California, Davis. The findings may help develop a marker to identify anxiety in FXS patients and open avenues for future treatment options.

In the study, first author Jessica Burris and colleagues studied attention to emotional faces in 47 children with FXS, ranging from several months to about 5.5 years old, compared with typically developing children. The researchers tracked eye gaze while the participants viewed pairs of face images that were presented very briefly, followed by a probe image on the same side as one of the faces. By comparing how quickly a participant fixated on the probe when it replaced an emotional (angry or happy) face versus a neutral face, they were able to calculate a "vigilance" or bias towards emotional faces.

"We demonstrate for the first time that young children with FXS show a significantly greater bias towards threatening than positive emotions than do typically developing children," said Rivera. Typically developing children showed a bias toward happy faces that was not apparent in the children with FXS.

"The results of this study by the Rivera lab are highly interesting because anxiety is a prominent aspect of the fragile X clinical presentation and the bias toward threatening information in these subjects parallels those seen in other clinical groups with prominent anxiety," said Dr. Cameron Carter, Editor of Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. "While we cannot presume that this reflects a common neurobiological substrate for anxiety disorders (though this could be the case), it does seem that this is the case at a cognitive mechanistic level," he added.

Studying attentional bias in infants and children, particularly those with neurodevelopmental disorders, has been difficult in the past because of the challenging procedures required by typical neuroimaging techniques. But the design of this study using passive viewing of images solved this problem. "These data support the utilization of eye tracking methodology to index neural and attentional responses in young children with FXS and other atypically developing populations," said Rivera.

According to Rivera, the findings provide a target for treatment of anxiety in FXS through the modification of attention bias toward positive emotion rather than threat, which has been shown to work in children with symptoms of anxiety.


Notes for editors

The article is "Children with Fragile X Syndrome Display Threat-Specific Biases Toward Emotion," by Jessica L. Burris, Ryan A. Barry-Anwar, Riley N. Sims, Randi J. Hagerman, Flora Tassone, and Susan M. Rivera ( It appears in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, volume 2, issue 6 (September 2017), published by Elsevier.

Copies of this paper are available to credentialed journalists upon request; please contact Rhiannon Bugno at or +1 214 648 0880. Journalists wishing to interview the authors may contact Susan Rivera, Ph.D. at [Phone number (add country code!)].

The authors' affiliations and disclosures of financial and conflicts of interests are available in the article.

Cameron S. Carter, M.D., is Professor of Psychiatry and Psychology and Director of the Center for Neuroscience at the University of California, Davis. His disclosures of financial and conflicts of interests are available here.

About Biological Psychiatry: Cognitive Neuroscience and Neuroimaging

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging is an official journal of the Society of Biological Psychiatry, whose purpose is to promote excellence in scientific research and education in fields that investigate the nature, causes, mechanisms and treatments of disorders of thought, emotion, or behavior. In accord with this mission, this peer-reviewed, rapid-publication, international journal focuses on studies using the tools and constructs of cognitive neuroscience, including the full range of non-invasive neuroimaging and human extra- and intracranial physiological recording methodologies. It publishes both basic and clinical studies, including those that incorporate genetic data, pharmacological challenges, and computational modeling approaches.

About Elsevier

Elsevier is a global information analytics company that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a world-leading provider of information and analytics to professionals and business customers, in a wide range of industries.

Media contact

Rhiannon Bugno
Editorial Office, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
+1 214 648 0880

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.